103 related articles for article (PubMed ID: 20729715)
21. [5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatine].
Jiang XZ; Li YF; Zhang YZ; Chen HX; Li J; Wang NP
Yao Xue Xue Bao; 2008 May; 43(5):467-73. PubMed ID: 18717332
[TBL] [Abstract][Full Text] [Related]
22. Alpha2-adrenoceptor antagonism is neither sufficient nor necessary for the distinctive action of atypical neuroleptics on intracranial self-stimulation in the rat.
Montgomery AM; Grottick AJ; Herberg LJ
Behav Pharmacol; 2003 Jul; 14(4):307-14. PubMed ID: 12838036
[TBL] [Abstract][Full Text] [Related]
23. Does antagonism at 5-HT2A receptors potentiate D₂ blockade-induced disruption of conditioned avoidance response?
Gao J; Huang Y; Li M
Exp Clin Psychopharmacol; 2019 Apr; 27(2):103-108. PubMed ID: 30556732
[TBL] [Abstract][Full Text] [Related]
24. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
Brocco M; Dekeyne A; Papp M; Millan MJ
Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
[TBL] [Abstract][Full Text] [Related]
25. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
[TBL] [Abstract][Full Text] [Related]
26. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
[TBL] [Abstract][Full Text] [Related]
27. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.
Berglind WJ; Case JM; Parker MP; Fuchs RA; See RE
Neuroscience; 2006; 137(2):699-706. PubMed ID: 16289883
[TBL] [Abstract][Full Text] [Related]
28. Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats.
Wiker C; Schilström B; Sandbäck C; Wadenberg ML; Svensson TH
Int J Neuropsychopharmacol; 2008 Sep; 11(6):845-50. PubMed ID: 18405415
[TBL] [Abstract][Full Text] [Related]
29. The role of alpha2-adrenoceptor antagonism in the anti-cataleptic properties of the atypical neuroleptic agent, clozapine, in the rat.
Kalkman HO; Neumann V; Hoyer D; Tricklebank MD
Br J Pharmacol; 1998 Aug; 124(7):1550-6. PubMed ID: 9723970
[TBL] [Abstract][Full Text] [Related]
30. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
Eltayb A; Wadenberg ML; Svensson TH
Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
Misane I; Johansson C; Ogren SO
Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333
[TBL] [Abstract][Full Text] [Related]
32. The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone.
Horisawa T; Nishikawa H; Toma S; Ikeda A; Horiguchi M; Ono M; Ishiyama T; Taiji M
Behav Brain Res; 2013 May; 244():66-9. PubMed ID: 23376699
[TBL] [Abstract][Full Text] [Related]
33. Noradrenergic influences in the basolateral amygdala on inhibitory avoidance memory are mediated by an action on α2-adrenoceptors.
Ferry B; Parrot S; Marien M; Lazarus C; Cassel JC; McGaugh JL
Psychoneuroendocrinology; 2015 Jan; 51():68-79. PubMed ID: 25286225
[TBL] [Abstract][Full Text] [Related]
34. Effects of dopamine antagonists in a two-way active avoidance procedure in rats: interactions with 8-OH-DPAT, ritanserin, and prazosin.
Prinssen EP; Kleven MS; Koek W
Psychopharmacology (Berl); 1996 Nov; 128(2):191-7. PubMed ID: 8956380
[TBL] [Abstract][Full Text] [Related]
35. Scopolamine does not restore normal conditioned avoidance performance in raclopride-treated rats.
Ahlenius S; Ericson E
J Neural Transm (Vienna); 2001; 108(4):415-30. PubMed ID: 11475009
[TBL] [Abstract][Full Text] [Related]
36. Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine.
Björkholm C; Jardemark K; Marcus MM; Malmerfelt A; Nyberg S; Schilström B; Svensson TH
Eur Neuropsychopharmacol; 2013 Jul; 23(7):709-20. PubMed ID: 22732518
[TBL] [Abstract][Full Text] [Related]
37. The potent α
Frau R; Devoto P; Aroni S; Saba P; Sagheddu C; Siddi C; Santoni M; Carli M; Gessa GL
Neuropharmacology; 2022 Oct; 217():109192. PubMed ID: 35850212
[TBL] [Abstract][Full Text] [Related]
38. Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.
Gao J; Qin R; Li M
J Psychopharmacol; 2015 Apr; 29(4):390-400. PubMed ID: 25586399
[TBL] [Abstract][Full Text] [Related]
39. Descending modulation of neuropathic hypersensitivity by dopamine D2 receptors in or adjacent to the hypothalamic A11 cell group.
Wei H; Viisanen H; Pertovaara A
Pharmacol Res; 2009 May; 59(5):355-63. PubMed ID: 19416636
[TBL] [Abstract][Full Text] [Related]
40. Clozapine reversal of the deficits in coordinated movement induced by D2 receptor blockade does not depend upon antagonism of alpha2 adrenoceptors.
McAllister KH; Rey B
Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):603-8. PubMed ID: 10619175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
